TELEMED - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 4,144,819 | 4,699,224 | 3,482,172 | 4,637,463 | 6,759,887 | 7,577,402 | 3,825,351 | 4,896,885 |
| Profit before tax | 858,392 | 1,251,920 | 845,787 | 1,503,667 | 1,183,598 | 1,217,036 | 505,957 | 1,123,772 |
| Net profit | 726,328 | 1,057,369 | 716,254 | 1,274,842 | 1,003,548 | 1,032,331 | 427,664 | 942,861 |
| Equity | 1,374,498 | 1,931,867 | 1,748,121 | 2,422,963 | 2,426,511 | 1,658,843 | 836,507 | 1,359,368 |
| Liabilities | 407,171 | 201,277 | 50,104 | 258,510 | 188,444 | 1,014,306 | 1,299,188 | 939,912 |
| Non-current assets | 111,663 | 85,750 | 64,515 | 37,685 | 19,464 | 33,471 | 129,239 | 118,366 |
| Current assets | 1,670,006 | 2,047,394 | 1,733,710 | 2,643,788 | 2,595,491 | 2,639,678 | 2,114,676 | 2,272,011 |
| Total assets | 1,781,669 | 2,133,144 | 1,798,225 | 2,681,473 | 2,614,955 | 2,673,149 | 2,243,915 | 2,390,377 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 450,846 | 375,790 | 316,534 |
| Social insurance contributions | - | - | - | - | - | 254,262 | 292,335 | 322,029 |
|
Financial indicators
|
||||||||
| Revenue change y/y | -9.2% | +13.4% | -25.9% | +33.2% | +45.8% | +12.1% | -49.5% | +28.0% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 40.8% | 49.6% | 39.8% | 47.5% | 38.4% | 38.6% | 19.1% | 39.4% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 52.8% | 54.7% | 41.0% | 52.6% | 41.4% | 62.2% | 51.1% | 69.4% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 17.5% | 22.5% | 20.6% | 27.5% | 14.8% | 13.6% | 11.2% | 19.3% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 20.7% | 26.6% | 24.3% | 32.4% | 17.5% | 16.1% | 13.2% | 22.9% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.3 | 0.1 | 0.0 | 0.1 | 0.1 | 0.6 | 1.6 | 0.7 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 186,284 | 196,483 | 151,399 | 205,349 | 307,268 | 339,287 | 172,572 | 222,586 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
TELEMED - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2022-10-28 | 2022-11-02 | 0.10 |
| 2022-08-23 | 2022-08-29 | 23.63 |
TELEMED - VMI tax arrears
The company had no tax arrears (debts) to the State Tax Inspectorate
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
TELEMED, UAB (code 121279814) is a Private Limited Liability Company engaged in the manufacture of irradiation, electromedical and electrotherapeutic equipment. In financial year 2025, the company generated revenue of EUR 4.90 million, up 28.0% year on year from EUR 3.83 million in 2024, although still below the EUR 7.58 million reported in 2023. Net profit in 2025 reached EUR 942.9 thousand, compared with EUR 427.7 thousand in 2024 and EUR 1.03 million in 2023, showing a clear recovery in profitability after the weaker 2024 result. The 2025 profit margin was 19.3%, above 11.2% in 2024 and 13.6% in 2023. At year-end 2025, total assets stood at EUR 2.39 million, equity at EUR 1.36 million and liabilities at EUR 939.9 thousand, indicating a solid equity position. Key ratios for 2025 show strong efficiency, with ROE at 69.4%, ROA at 39.4%, debt-to-equity at 0.69 and asset turnover at 2.05x. Revenue per employee was EUR 222.6 thousand, supporting a relatively productive operating profile.